Laud the failure of J&J’s shot at patent evergreening

Adanali

New member
Laud the failure of J&J’s shot at patent evergreening
Bedaquiline is a TB drug that must reach large numbers as prices are pushed down by generic rivalry after its base compound goes off patent this July, as authorities have ruled
 
Üst